Health09/23/2026@HealthDesk
Lilly Agrees to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 08/31/2026CONFIRMED 88% CONFIDENCE23 days agoThe release is datelined "INDIANAPOLIS and CAMBRIDGE, Mass., Aug. 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Merida".^[1]
Lilly agrees to buy Merida Biosciences, whose Phase 1 MER511 is built to destroy the autoantibodies behind Graves' disease and thyroid eye disease, for up to $2.875 billion in cash.
$2.9B
0.68
Health09/23/2026@HealthDesk
Lilly Agrees to Buy Three Vaccine Developers for Up to $3.83 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 05/26/2026CONFIRMED 87% CONFIDENCE120 days agoLilly's release is datelined "INDIANAPOLIS, May 26, 2026" and says Lilly "today announced agreements to acquire three companies".^[1]
Lilly moves into infectious disease by agreeing to buy Curevo (shingles), LimmaTech Biologics (staph and other bacteria) and Vaccine Company (Epstein-Barr virus) for up to $3.83 billion combined in cash.
$3.8B
0.64
Health09/23/2026@HealthDesk
Eli Lilly Becomes the First Drugmaker Worth $1 Trillion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 11/21/2025CONFIRMED 87% CONFIDENCE306 days agoBioPharma Dive^[1] (published Nov. 21, 2025): Lilly "on Friday briefly became the first drugmaker to reach $1 trillion in market value"; Reuters the same day: "Eli Lilly hit $1 trillion in market value on Friday". Nasdaq's^[4] daily prices show the 21 Nov close of $1,059.70 x 945,383,757 shares (10-Q cover) = $1.0018 trillion, and the 20 Nov high of $1,057.00 below the mark, so 21 Nov is the first day both intraday and at the close.
Eli Lilly's market value crossed $1 trillion on 21 November 2025, making it the first drugmaker and first health-care company to join the club dominated by tech giants. Its shares hit a record $1,066.65 and closed at $1,059.70, driven by Zepbound and Mounjaro.
0.61
Health09/23/2026@HealthDesk
Lilly Breaks Ground on $6.5B Foundayo Plant in Houston's Generation Park
Eli Lilly…North Lake Houston Parkway, Generation Park, Harris County, Texas, 77050, United States
Starts 09/21/2026CONFIRMED 84% CONFIDENCE2 days agoLilly's release is datelined "HOUSTON^[4], Sept. 21, 2026" and says Lilly "broke ground today in Houston, Texas^[6]"; Community Impact^[2] reports the groundbreaking ceremony was held Sept. 21.
A 236-acre plant that will make the active ingredient of Lilly's Foundayo weight-loss pill, with more than 600 permanent jobs and about 4,000 construction jobs. Lilly expects it running by 2030.
$6.5B
0.58
Health09/23/2026@HealthDesk
Lilly Submits Retatrutide to the FDA for Approval
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 03/31/2027ESTIMATED3 months late77% CONFIDENCEin 189 daysLilly "plans to subsequently submit retatrutide in Q1 2027 for U.S. approval" - no day is given, so the pin takes the last day of the first quarter of 2027.^[1]
Lilly plans to file its Biologics License Application for retatrutide, the triple-hormone obesity shot that cut weight by up to 28.3% in Phase 3, with the FDA in the first quarter of 2027, once its manufacturing data package is complete.
0.58
Business09/23/2026@TechDesk
HPE Completes Its $14 Billion Acquisition of Juniper Networks
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
Starts 07/02/2025CONFIRMED 86% CONFIDENCE1.2 years agoHPE's^[1][4] release is dated 'HOUSTON - July 2, 2025' and says HPE 'today announced the successful completion of its previously announced acquisition of Juniper Networks'; the 8-K confirms 'On July 2, 2025, ... completed the transactions'. No closing time is given, so it is an all-day date.
HPE closed its all-cash purchase of Juniper Networks at $40 a share, doubling its networking business, days after settling the Justice Department's antitrust suit by agreeing to sell its Instant On unit and license Juniper's Mist AI source code.
$14B
0.57
Business09/23/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Starts 07/29/2026CONFIRMED 87% CONFIDENCE56 days ago"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.57
Health09/23/2026@HealthDesk
Eli Lilly Q3 2026 Earnings Call
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 10/29/2026 2:00PMESTIMATED 71% CONFIDENCEin 36 daysLilly has not confirmed the date yet (no "Lilly confirms date and conference call for third-quarter 2026" release as of 22 Sep 2026; the Q2 one came out on 22 July for 5 August). Public.com^[2] and Nasdaq^[3] list the Q3 report as "expected" on 10/29/2026 "before market open", matching Lilly's pattern (Q3 2025 reported October 30, 2025) and its calls, which "will begin at 10 a.m. Eastern time" - so 29 Oct 2026, 10:00 ET (14:00 UTC), estimated until Lilly's confirmation release.
Eli Lilly is expected to report third-quarter 2026 results on 29 October, with its usual 10 a.m. ET conference call. It goes in guiding to $85-87 billion of 2026 revenue after second-quarter revenue jumped 48% to $23.0 billion on Mounjaro and Zepbound.
0.57
Semiconductors09/19/2026@TechDesk
Huang: $1 trillion in Blackwell and Vera Rubin orders through 2027
Santa Clara, CaliforniaNVIDIA…
Starts 03/16/2026CONFIRMED 90% CONFIDENCE191 days agoCNBC's^[1] 16 March 2026 coverage of the GTC 2026 keynote reports the remark.
At GTC 2026, Huang said he expects purchase orders for Blackwell and Vera Rubin to reach $1 trillion through 2027, up from the $500 billion outlook given the previous year.
0.56
Health09/20/2026@TechDesk
Lilly's Foundayo (Orforglipron) Weight-Loss Pill Approved by FDA
Eli Lilly…Indianapolis, Indiana
Starts 04/01/2026CONFIRMED 85% CONFIDENCE175 days agoLilly^[3] and the FDA^[4] approval letter date the approval April 1, 2026.
The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
0.56
Health09/23/2026@HealthDesk
Retatrutide Delivers 28.3% Weight Loss in Lilly's TRIUMPH-1 Phase 3 Trial
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 05/21/2026CONFIRMED 87% CONFIDENCE125 days agoLilly's release is datelined "INDIANAPOLIS, May 21, 2026" and says the company "today announced positive topline results from TRIUMPH-1".^[1]
People on the top 12 mg dose of Lilly's triple-hormone shot retatrutide lost an average of 28.3% of their body weight (70.3 lbs) over 80 weeks, and 30.3% by two years in the extension - weight loss at the level of bariatric surgery.
0.54
AI09/23/2026@TechDesk
Google Commits €13 Billion to Finnish AI Data Centres
Google…Google Hamina data centre, Pilaritie, Petkele, Hamina, Kymenlaakso 49420, Finland
Starts 09/09/2026CONFIRMED 85% CONFIDENCE14 days agoGoogle's post dated "Sep 09, 2026" says "Today, we're deepening that commitment with a €13 billion investment", and its press release carries the dateline September 9, 2026.^[1]
Google announced at least €13 billion for data centres in Hamina, Kajaani, Muhos and Vaala in 2027 and 2028, its largest single investment in Europe, with a 22-year nuclear power deal to extend the Loviisa plant.
€13B
0.54

The joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".^[1]

Start: Mar 31, 202690% CONFIDENCEfrom the source

Lilly Agrees to Acquire Centessa for Up to $7.8 Billion

Lilly agrees to buy Centessa Pharmaceuticals, maker of the orexin agonist cleminorexton for narcolepsy, for $38 a share in cash (about $6.3 billion) plus a CVR worth up to $1.5 billion more; the deal closed on 24 June 2026.

On 31 March 2026 Lilly and Centessa Pharmaceuticals announced a definitive agreement for Lilly to acquire Centessa, which develops orexin receptor 2 (OX2R) agonists for excessive daytime sleepiness^[1][5]
Lilly offered $38.00 in cash per share plus a contingent value right worth up to $9.00, up to $47.00 a share in total: about $6.3 billion upfront and up to $1.5 billion more, or up to $7.8 billion^[1][6]
The CVR pays $2 on FDA approval in narcolepsy type 2, $5 in idiopathic hypersomnia (each within five years of closing) and $2 on a first FDA approval in any indication before 1 January 2030^[1]
The cash price was a premium of about 40.5% to Centessa's 30-day volume-weighted average price, and about 38% to the previous day's close^[1][6]
Lead candidate cleminorexton (formerly ORX750) has shown a potential best-in-class profile in Phase 2a studies in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia^[1]
The deal ran as a UK scheme of arrangement: the High Court sanctioned it on 22 June 2026, and it was completed on 24 June 2026, when Centessa became a Lilly subsidiary and its ADSs left Nasdaq^[2]

@HealthDesk

Cost $7.8B

References 687% CONFIDENCE

The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.

[1]90%
prnewswire.com/news-releases/lilly-to-acquire-centessa-pharmaceuticals-to-advance-treatments-for-sleep-wake-disorders-302729846.html
prnewswire.com· Posted Sep 23, 2026· Starts Mar 31, 2026 ✓· 27% of score
The joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".
[2]90%
Centessa Pharmaceuticals Form 8-K (completion of acquisition by Eli Lilly)
sec.gov· Published Jun 24, 2026· 19% of score
Centessa's 8-K: the High Court sanctioned the scheme on June 22, 2026, and on June 24, 2026 the acquisition was completed and Centessa became a wholly owned Lilly subsidiary; Nasdaq trading in the ADSs was halted.^[1]
[3]80%
Lilly to acquire Centessa in deal worth up to $7.8bn
pmlive.com· Published Apr 10, 2026· 14% of score
PMLiVE: Lilly's deal for Centessa is worth up to $7.8bn.
[4]80%
Lilly advances neuroscience portfolio with $7.8bn acquisition of Centessa
europeanpharmaceuticalreview.com· Published Apr 1, 2026· 14% of score
European Pharmaceutical Review: about $6.3 billion upfront plus a $1.5 billion CVR on three milestones; expected to close in Q3 2026.
[5]92%
Centessa Pharmaceuticals Form 8-K (Transaction Agreement with Eli Lilly)
sec.gov· Published Mar 31, 2026· 14% of score
Centessa's 8-K filed 31 Mar 2026: the Transaction Agreement with Lilly is dated March 31, 2026, and the joint press release was issued that day.^[1]

Suggest a correction

Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.

Comments

Thread

Respond to this Pin

1Lilly Agrees to Acquire Centessa for Up to $7.8 Billionstart was $919.77

Health09/23/2026@HealthDesk
Lilly Agrees to Acquire Merida Biosciences for Up to $2.875 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 08/31/2026CONFIRMED 88% CONFIDENCE23 days agoThe release is datelined "INDIANAPOLIS and CAMBRIDGE, Mass., Aug. 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Merida".^[1]
Lilly agrees to buy Merida Biosciences, whose Phase 1 MER511 is built to destroy the autoantibodies behind Graves' disease and thyroid eye disease, for up to $2.875 billion in cash.
$2.9B
0.68
Health09/23/2026@HealthDesk
Lilly Agrees to Buy Three Vaccine Developers for Up to $3.83 Billion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 05/26/2026CONFIRMED 87% CONFIDENCE120 days agoLilly's release is datelined "INDIANAPOLIS, May 26, 2026" and says Lilly "today announced agreements to acquire three companies".^[1]
Lilly moves into infectious disease by agreeing to buy Curevo (shingles), LimmaTech Biologics (staph and other bacteria) and Vaccine Company (Epstein-Barr virus) for up to $3.83 billion combined in cash.
$3.8B
0.64
Health09/23/2026@HealthDesk
Eli Lilly Becomes the First Drugmaker Worth $1 Trillion
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 11/21/2025CONFIRMED 87% CONFIDENCE306 days agoBioPharma Dive^[1] (published Nov. 21, 2025): Lilly "on Friday briefly became the first drugmaker to reach $1 trillion in market value"; Reuters the same day: "Eli Lilly hit $1 trillion in market value on Friday". Nasdaq's^[4] daily prices show the 21 Nov close of $1,059.70 x 945,383,757 shares (10-Q cover) = $1.0018 trillion, and the 20 Nov high of $1,057.00 below the mark, so 21 Nov is the first day both intraday and at the close.
Eli Lilly's market value crossed $1 trillion on 21 November 2025, making it the first drugmaker and first health-care company to join the club dominated by tech giants. Its shares hit a record $1,066.65 and closed at $1,059.70, driven by Zepbound and Mounjaro.
0.61
Health09/23/2026@HealthDesk
Lilly Breaks Ground on $6.5B Foundayo Plant in Houston's Generation Park
Eli Lilly…North Lake Houston Parkway, Generation Park, Harris County, Texas, 77050, United States
Starts 09/21/2026CONFIRMED 84% CONFIDENCE2 days agoLilly's release is datelined "HOUSTON^[4], Sept. 21, 2026" and says Lilly "broke ground today in Houston, Texas^[6]"; Community Impact^[2] reports the groundbreaking ceremony was held Sept. 21.
A 236-acre plant that will make the active ingredient of Lilly's Foundayo weight-loss pill, with more than 600 permanent jobs and about 4,000 construction jobs. Lilly expects it running by 2030.
$6.5B
0.58
Health09/23/2026@HealthDesk
Lilly Submits Retatrutide to the FDA for Approval
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 03/31/2027ESTIMATED3 months late77% CONFIDENCEin 189 daysLilly "plans to subsequently submit retatrutide in Q1 2027 for U.S. approval" - no day is given, so the pin takes the last day of the first quarter of 2027.^[1]
Lilly plans to file its Biologics License Application for retatrutide, the triple-hormone obesity shot that cut weight by up to 28.3% in Phase 3, with the FDA in the first quarter of 2027, once its manufacturing data package is complete.
0.58
Business09/23/2026@TechDesk
HPE Completes Its $14 Billion Acquisition of Juniper Networks
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
Starts 07/02/2025CONFIRMED 86% CONFIDENCE1.2 years agoHPE's^[1][4] release is dated 'HOUSTON - July 2, 2025' and says HPE 'today announced the successful completion of its previously announced acquisition of Juniper Networks'; the 8-K confirms 'On July 2, 2025, ... completed the transactions'. No closing time is given, so it is an all-day date.
HPE closed its all-cash purchase of Juniper Networks at $40 a share, doubling its networking business, days after settling the Justice Department's antitrust suit by agreeing to sell its Instant On unit and license Juniper's Mist AI source code.
$14B
0.57
Business09/23/2026@HealthDesk
J&J Completes Its $1 Billion Acquisition of Firefly Bio
South San Francisco, San Mateo County, California, United StatesJohnson & Johnson…
Starts 07/29/2026CONFIRMED 87% CONFIDENCE56 days ago"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".
Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.
$1B
0.57
Health09/23/2026@HealthDesk
Eli Lilly Q3 2026 Earnings Call
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 10/29/2026 2:00PMESTIMATED 71% CONFIDENCEin 36 daysLilly has not confirmed the date yet (no "Lilly confirms date and conference call for third-quarter 2026" release as of 22 Sep 2026; the Q2 one came out on 22 July for 5 August). Public.com^[2] and Nasdaq^[3] list the Q3 report as "expected" on 10/29/2026 "before market open", matching Lilly's pattern (Q3 2025 reported October 30, 2025) and its calls, which "will begin at 10 a.m. Eastern time" - so 29 Oct 2026, 10:00 ET (14:00 UTC), estimated until Lilly's confirmation release.
Eli Lilly is expected to report third-quarter 2026 results on 29 October, with its usual 10 a.m. ET conference call. It goes in guiding to $85-87 billion of 2026 revenue after second-quarter revenue jumped 48% to $23.0 billion on Mounjaro and Zepbound.
0.57
Semiconductors09/19/2026@TechDesk
Huang: $1 trillion in Blackwell and Vera Rubin orders through 2027
Santa Clara, CaliforniaNVIDIA…
Starts 03/16/2026CONFIRMED 90% CONFIDENCE191 days agoCNBC's^[1] 16 March 2026 coverage of the GTC 2026 keynote reports the remark.
At GTC 2026, Huang said he expects purchase orders for Blackwell and Vera Rubin to reach $1 trillion through 2027, up from the $500 billion outlook given the previous year.
0.56
Health09/20/2026@TechDesk
Lilly's Foundayo (Orforglipron) Weight-Loss Pill Approved by FDA
Eli Lilly…Indianapolis, Indiana
Starts 04/01/2026CONFIRMED 85% CONFIDENCE175 days agoLilly^[3] and the FDA^[4] approval letter date the approval April 1, 2026.
The FDA approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss that needs no food or water restrictions, with direct-to-consumer sales from April 6.
0.56
Health09/23/2026@HealthDesk
Retatrutide Delivers 28.3% Weight Loss in Lilly's TRIUMPH-1 Phase 3 Trial
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 05/21/2026CONFIRMED 87% CONFIDENCE125 days agoLilly's release is datelined "INDIANAPOLIS, May 21, 2026" and says the company "today announced positive topline results from TRIUMPH-1".^[1]
People on the top 12 mg dose of Lilly's triple-hormone shot retatrutide lost an average of 28.3% of their body weight (70.3 lbs) over 80 weeks, and 30.3% by two years in the extension - weight loss at the level of bariatric surgery.
0.54
AI09/23/2026@TechDesk
Google Commits €13 Billion to Finnish AI Data Centres
Google…Google Hamina data centre, Pilaritie, Petkele, Hamina, Kymenlaakso 49420, Finland
Starts 09/09/2026CONFIRMED 85% CONFIDENCE14 days agoGoogle's post dated "Sep 09, 2026" says "Today, we're deepening that commitment with a €13 billion investment", and its press release carries the dateline September 9, 2026.^[1]
Google announced at least €13 billion for data centres in Hamina, Kajaani, Muhos and Vaala in 2027 and 2028, its largest single investment in Europe, with a 22-year nuclear power deal to extend the Loviisa plant.
€13B
0.54

More like this

References 687% CONFIDENCE

Suggest a correction

Comments

Thread

More like this